Ingenium Pharmaceuticals' Unattributed VC Round

Ingenium Pharmaceuticals raised a round of funding on September 12, 2000.

Ingenium focuses on phenotype-driven target discovery and validation via chemical mutagenesis in mice.…

Articles about Ingenium Pharmaceuticals' Unattributed VC Round: